動脈動脈粥狀硬化斑塊切除術器械市場規模、佔有率和成長分析(按產品、應用、最終用戶和地區分類)—產業預測(2026-2033 年)
市場調查報告書
商品編碼
1895975

動脈動脈粥狀硬化斑塊切除術器械市場規模、佔有率和成長分析(按產品、應用、最終用戶和地區分類)—產業預測(2026-2033 年)

Atherectomy Devices Market Size, Share, and Growth Analysis, By Product (Directional Atherectomy Devices, Orbital Atherectomy Devices), By Application (Peripheral Vascular, Cardiovascular), By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 186 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球動脈粥狀硬化斑塊切除術設備市場規模預計在 2024 年達到 11.2 億美元,從 2025 年的 12.2 億美元成長到 2033 年的 22.7 億美元,在預測期(2026-2033 年)內複合年成長率為 8.1%。

全球心血管疾病盛行率的不斷上升預計將顯著推動對動脈動脈粥狀硬化斑塊切除術器械的需求。人口老化、不健康的生活方式和飲食習慣等因素共同導致心血管疾病發生率上升,加劇了這種需求成長。此外,微創手術日益受到青睞,預計將為動脈粥狀硬化斑塊切除術器械供應商帶來新的發展機會。對醫療研發的投資有望推動該領域的技術進步,創造更多成長機會。然而,動脈粥狀硬化斑塊切除術手術的高成本、潛在併發症以及替代治療方法的存在等挑戰,可能會在長期內阻礙市場擴張。總而言之,動脈粥狀硬化斑塊切除術器械市場既蘊藏著巨大的發展機遇,也面臨許多挑戰。

全球動脈動脈粥狀硬化斑塊切除術器械市場促進因素

隨著老化社會的加劇,心血管疾病(尤其是動脈阻塞)的盛行率不斷上升,這成為推動動脈粥狀硬化斑塊切除術器械需求成長的主要因素。老年人尋求有效的治療方法,使得先進的醫療干預措施變得至關重要。此外,老年患者越來越傾向於選擇微創動脈動脈粥狀硬化斑塊切除術術,這有助於改善他們的康復和舒適度。這一趨勢不僅凸顯了動脈粥狀硬化斑塊切除術器械在心血管疾病管理中的重要性,也表明隨著醫療服務提供者不斷調整以滿足老年患者的需求,動脈粥狀硬化斑塊切除術器械市場潛力巨大,有望推動該行業未來的成長。

限制全球動脈動脈粥狀硬化斑塊切除術硬化切除器械市場的因素

動脈粥狀硬化斑塊切除術術中潛在的併發症對全球動脈動脈粥狀硬化斑塊切除術器械市場構成重大障礙。由於多種因素相互交織,有效管理每個環節往往極具挑戰性,導致固有風險無法完全消除。對這些手術安全性的不確定性可能導致醫護人員和患者都持謹慎態度,最終阻礙動脈動脈粥狀硬化斑塊切除術器械的成長和銷售。隨著醫學界權衡風險和效益,這種疑慮可能會減緩市場成長,並影響該行業的整體產生收入。

全球動脈粥狀硬化斑塊切除術器械市場趨勢

全球動脈粥狀硬化斑塊切除術器械市場正呈現出顯著的趨勢,即整合先進技術,尤其是人工智慧 (AI) 和機器學習。製造商正利用這些創新來提升器材的功能和精準度,最終改善病患的治療效果。透過整合先進的分析技術和自動化流程,企業可以簡化研發和部署流程,提高治療的效率和效果。這種技術革新不僅帶來了競爭優勢,也透過滿足日益成長的、對更先進、更有效的介入心臟病學的需求,拓展了業務機會。因此,在技術進步的驅動下,預計該市場未來將迎來顯著成長。

目錄

介紹

  • 調查目標
  • 市場定義和範圍

調查方法

  • 調查過程
  • 二手資料和一手資料方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 主要市場亮點
  • 細分市場概覽
  • 競賽概況

市場動態與展望

  • 總體經濟指標
  • 促進因素和機遇
  • 限制與挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場考察

  • 關鍵成功因素
  • 影響市場的因素
  • 關鍵投資機會
  • 生態系測繪
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 監管環境
  • 技術評估

全球動脈粥狀硬化斑塊切除術器械市場規模(按產品和複合年成長率分類)(2026-2033 年)

  • 定向斑塊動脈粥狀硬化斑塊切除術裝置
  • 軌道動脈動脈粥狀硬化斑塊切除術裝置
  • 光消融動脈粥狀斑塊動脈粥狀硬化斑塊切除術裝置
  • 旋轉式動脈粥狀硬化斑塊切除術裝置
  • 支援的設備
  • 其他

全球動脈粥狀硬化斑塊切除術器械市場規模(按應用及複合年成長率分類)(2026-2033 年)

  • 周邊血管
  • 心血管系統
  • 神經血管

全球動脈粥狀硬化斑塊切除術器械市場規模(按最終用戶分類)及複合年成長率(2026-2033 年)

  • 醫院和診所
  • 門診治療中心
  • 研究機構和學術機構
  • 其他

全球動脈粥狀硬化斑塊切除術器械市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Medtronic Plc(Ireland)
  • Boston Scientific Corporation(USA)
  • Cardiovascular Systems, Inc.(USA)
  • Royal Philips(Netherlands)
  • Avinger, Inc.(USA)
  • Terumo Corporation(Japan)
  • AngioDynamics, Inc.(USA)
  • Braun Group(Germany)
  • Abbott Laboratories(USA)
  • B. Braun Melsungen AG(Germany)
  • Biotronik SE & Co. KG(Germany)
  • Biomerics(USA)
  • Philips(Netherlands)
  • Cook Medical, Inc.(USA)
  • Cardinal Health, Inc.(USA)
  • Rex Medical, LP(USA)
  • WL Gore & Associates, Inc.(USA)
  • Minnetronix, Inc.(USA)
  • Merit Medical Systems, Inc.(USA)
  • NexStep Medical(USA)

結論與建議

簡介目錄
Product Code: SQMIG35A2953

Global Atherectomy Devices Market size was valued at USD 1.12 Billion in 2024 and is poised to grow from USD 1.22 Billion in 2025 to USD 2.27 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The growing prevalence of cardiovascular disorders globally is anticipated to significantly drive the demand for atherectomy devices. This surge is influenced by an aging population, unhealthy lifestyle choices, and dietary habits, all contributing to a higher incidence of cardiovascular conditions. Additionally, the increasing preference for minimally invasive procedures is expected to open new avenues for atherectomy device providers. Investment in medical research and development is likely to result in technological advancements within this sector, creating further opportunities for growth. However, challenges such as the high costs associated with atherectomy procedures, the potential for complications, and the availability of alternative treatments could hinder market expansion in the long term. Overall, the atherectomy devices market presents both dynamic opportunities and notable challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Atherectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Atherectomy Devices Market Segments Analysis

Global Atherectomy Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, Support Devices, and Others. Based on Application, the market is segmented into Peripheral Vascular, Cardiovascular, and Neurovascular. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Atherectomy Devices Market

The increasing prevalence of cardiovascular issues, notably arterial blockages, among the aging population significantly drives the demand for atherectomy devices. As more elderly individuals seek effective treatments for these conditions, the necessity for advanced medical interventions becomes paramount. Additionally, there is a noticeable shift toward minimally invasive atherectomy procedures favored by geriatric patients, which enhances patient recovery and comfort. This trend not only highlights the importance of atherectomy devices in managing cardiovascular diseases but also underscores a growing market potential as healthcare providers adapt to meet the needs of this demographic, thereby fostering future growth in the atherectomy devices sector.

Restraints in the Global Atherectomy Devices Market

The potential for complications during atherectomy procedures poses a significant barrier in the global atherectomy devices market. Given the various factors at play, managing each aspect effectively is often unfeasible, leading to an inherent risk that cannot be entirely mitigated. This uncertainty surrounding the safety of such procedures may result in a cautious approach from healthcare professionals and patients alike, ultimately hindering the growth and sales of atherectomy devices. As the medical community weighs the benefits against the risks, this skepticism could contribute to a slowdown in market expansion, affecting overall revenue generation in the sector.

Market Trends of the Global Atherectomy Devices Market

The Global Atherectomy Devices market is witnessing a significant trend towards the integration of advanced technologies, particularly artificial intelligence and machine learning. Manufacturers are leveraging these innovations to enhance the functionality and precision of their devices, ultimately improving patient outcomes. By incorporating advanced analytics and automated processes, companies can streamline development and deployment, fostering greater efficiency and effectiveness in treatment. This technological evolution not only captures a competitive edge but also expands business potential by meeting the growing demand for more sophisticated and effective cardiovascular interventions. As such, the future of the market is poised for substantial growth driven by technological advancement.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape
  • Technology Assessment

Global Atherectomy Devices Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Directional Atherectomy Devices
  • Orbital Atherectomy Devices
  • Photo-Ablative Atherectomy Devices
  • Rotational Atherectomy Devices
  • Support Devices
  • Others

Global Atherectomy Devices Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Peripheral Vascular
  • Cardiovascular
  • Neurovascular

Global Atherectomy Devices Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Research Laboratories & Academic Institutes
  • Others

Global Atherectomy Devices Market Size & CAGR (2026-2033)

  • North America (Product, Application, End User)
    • US
    • Canada
  • Europe (Product, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic Plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiovascular Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Royal Philips (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avinger, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Braun Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rex Medical, L.P. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • W. L. Gore & Associates, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Minnetronix, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NexStep Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations